Europe — Revenue
Eli Lilly Europe — Revenue increased by 17.7% to $3.65B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.6%, from $2.39B to $3.65B. Over 4 years (FY 2021 to FY 2025), Europe — Revenue shows an upward trend with a 24.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful product adoption, favorable pricing, or expanded market access in Europe, while a decrease may signal increased competition, patent expirations, or regulatory pricing pressures.
Detailed definition
This metric represents the total gross sales generated from pharmaceutical products sold within the European geographic...
Peer comparison
Comparable to regional revenue reporting by other multinational pharmaceutical companies, which typically segment performance by major geographic regions to isolate localized market performance.
lly_segment_europe_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.21B | $1.10B | $1.15B | $1.07B | $1.10B | $1.06B | $1.07B | $1.09B | $1.18B | $2.57B | $1.34B | $1.44B | $1.40B | $1.63B | $2.45B | $2.39B | $2.57B | $3.50B | $3.10B | $3.65B |
| QoQ Change | — | -9.2% | +4.4% | -7.0% | +3.2% | -4.1% | +1.7% | +1.5% | +7.9% | +118.1% | -47.9% | +7.7% | -2.6% | +16.0% | +50.4% | -2.4% | +7.8% | +35.9% | -11.5% | +17.7% |
| YoY Change | — | — | — | — | -9.0% | -3.8% | -6.3% | +2.2% | +6.9% | +143.1% | +24.5% | +32.1% | +19.2% | -36.6% | +83.0% | +65.8% | +83.4% | +114.8% | +26.5% | +52.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's europe — revenue?
- Eli Lilly (LLY) reported europe — revenue of $3.65B in Q1 2026.
- How has Eli Lilly's europe — revenue changed year-over-year?
- Eli Lilly's europe — revenue increased by 52.6% year-over-year, from $2.39B to $3.65B.
- What is the long-term trend for Eli Lilly's europe — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's europe — revenue has grown at a 24.7% compound annual growth rate (CAGR), from $4.78B to $11.56B.
- What does europe — revenue mean?
- The total amount of money earned from selling pharmaceutical products in the European market.